We are live on ! Find out more
ENVB icon

Enveric Biosciences
ENVB

15 hedge funds and large institutions have $488K invested in Enveric Biosciences in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

50% more funds holding

Funds holding: 10 → 15 (+5)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.07% less ownership

Funds ownership: 0.12% → 0.05% (-0.07%)

23% less capital invested

Capital invested by funds: $636K → $488K (-$147K)

Holders
15
Holders Change
+5
Holders Change %
+50%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
+$104K
2
HF
HRT Financial
New York
+$67.4K
3
Citadel Advisors
Citadel Advisors
Florida
+$43K
4
VF
Virtu Financial
New York
+$36.2K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$19.5K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$355K
2
TRCT
Tower Research Capital (TRC)
New York
-$385
3
OP
ORG Partners
Indiana
-$13
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
AdvisorShares Investments
Maryland
$239K +$104K +539 +68%
HF
2
HRT Financial
New York
$63K +$67.4K +350 New
Citadel Advisors
3
Citadel Advisors
Florida
$40.1K +$43K +223 New
VF
4
Virtu Financial
New York
$34K +$36.2K +188 New
BlackRock
5
BlackRock
New York
$29.6K – – –
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$18.2K +$19.5K +101 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$18.2K – – –
Two Sigma Investments
8
Two Sigma Investments
New York
$15.4K +$16.6K +86 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$13.1K – – –
TRCT
10
Tower Research Capital (TRC)
New York
$12.3K -$385 -2 -3%
UBS Group
11
UBS Group
Switzerland
$4.98K +$5.4K +28 New
Group One Trading
12
Group One Trading
Illinois
$273 – – –
Osaic Holdings
13
Osaic Holdings
Arizona
$150 – – –
Bank of America
14
Bank of America
North Carolina
$100 – – –
National Bank of Canada
15
National Bank of Canada
Quebec, Canada
$63 – – –
Wells Fargo
16
Wells Fargo
California
$37 – – –
Morgan Stanley
17
Morgan Stanley
New York
$1 – – –
AC
18
Armistice Capital
New York
– -$355K -1,517 Closed
OP
19
ORG Partners
Indiana
– -$13 – –

ENVB Hedge Fund Activity: Q1 2024 in Review

15 of the 6,946 institutional investors tracked by Wall St. Rank reported a position in Enveric Biosciences (ENVB) for Q1 2024, worth a combined $488K — down 23% from $636K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ENVB positions and 1 closed out — a net gain of 5 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was AdvisorShares Investments, adding an estimated $104K. The largest seller was Armistice Capital, exiting entirely with an estimated $355K sold.

  • 15 institutional investors held Enveric Biosciences (ENVB) as of Q1 2024, up from 10 in Q4 2023.
  • Funds reported $488K of Enveric Biosciences stock for Q1 2024, down 23% quarter-over-quarter.
  • 6 funds opened new Enveric Biosciences positions in Q1 2024 and 1 closed out, a net change of +5 holders.
  • The largest Enveric Biosciences buyer in Q1 2024 was AdvisorShares Investments, an estimated $104K added.
  • The largest Enveric Biosciences seller in Q1 2024 was Armistice Capital, an estimated $355K sold.

Based on aggregated 13F filings for Q1 2024.